Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5824606 | Clinical Therapeutics | 2015 | 9 Pages |
Abstract
Treatment with PR OXN resulted in a significant and clinically relevant reduction in OIC compared with previous PR OXY treatment for these patients with severe chronic pain and laxative-refractory OIC. Treatment with PR OXN also resulted in a significant improvement in pain relief and quality of life. ClinicalTrials.gov identifier: NCT01710917.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Jan MD, PhD, Gineke MSc, Alioune MD, Frédéric MD, Mayken MD, David MD, Joeri PhD, Yvonne J.B. PhD,